|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the CVS 10-K filed Feb 27, 2007. Evaluation of disclosure controls and procedures: The Company’s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (f) and 15d-15(f)) as of December 30, 2006, have concluded that as of such date the Company’s disclosure controls and procedures were adequate and effective and designed to ensure that material information relating to the Company and its subsidiaries would be made known to such officers on a timely basis.
This excerpt taken from the CVS 10-Q filed May 9, 2005. Evaluation
of disclosure controls and procedures: The Company’s Chief
Executive Officer and Chief Financial Officer, after evaluating the
effectiveness of the design and operation of the Company’s disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15(e)) as
of April 2, 2005, have concluded that as of such date the Company’s disclosure
controls and procedures were adequate and effective and designed to ensure that
material information relating to the Company and its subsidiaries would be made
known to such officers on a timely basis.
| EXCERPTS ON THIS PAGE:
|
| |||||||
